Literature DB >> 30321570

Hemangioblastoma of the optic nerve.

Lindsay A McGrath1, Hardeep Singh Mudhar2, Sachin M Salvi3.   

Abstract

Optic nerve hemangioblastoma is a rare tumor that is usually unilateral and most commonly occurs in the context of von Hippel-Lindau disease. Differential diagnosis is based on clinical history and imaging. Magnetic resonance imaging with gadolinium enhancement is the most useful imaging modality as it can reveal flow voids and an absence of dural attachment, differentiating optic nerve hemangioblastoma from other more commonly encountered optic nerve tumors. Optic nerve hemangioblastoma are usually well-circumscribed vascular lesions composed of stromal cells and vascular endothelial cells. These lesions are diagnosed at a mean age of 37 years and can be asymptomatic, but over time, patients may develop reduction in vision, proptosis, and pain. Surgical excision is well described via orbital, transsphenoidal, or transcranial approaches. Given the risks associated with surgery, a stepwise conservative approach is advocated by most clinicians in the absence of severe symptoms. Although uncommon, this optic nerve tumor should be considered in young patients presenting with pain, proptosis, and optic nerve pallor, with or without a history of von Hippel-Lindau disease. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  hemangioblastoma; hemangioma; optic nerve; tumor; von Hippel-Lindau

Mesh:

Year:  2018        PMID: 30321570     DOI: 10.1016/j.survophthal.2018.10.002

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  2 in total

Review 1.  Central Nervous System Hemangioblastoma in a Pediatric Patient Associated With Von Hippel-Lindau Disease: A Case Report and Literature Review.

Authors:  Bo Yang; Zhenyu Li; Yubo Wang; Chaoling Zhang; Zhen Zhang; Xianfeng Zhang
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

2.  Optic nerve Hemangioblastoma with bilateral frontal lobe Oedema: a case report.

Authors:  Shujia Xu; Qian Li; Bingyang Bian; Hongli Zhou; Dan Li
Journal:  BMC Ophthalmol       Date:  2020-11-03       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.